Procedures for chronic total occlusion: when are they recommended and when not

Area of Science:

• Interventional Cardiology
• Cardiovascular Medicine
• Clinical Trials

Background:

• Coronary chronic total occlusion (CTO) presents a significant clinical challenge.
• Current treatments include medical therapy and coronary artery bypass grafting (CABG).
• Percutaneous coronary intervention (PCI) has emerged as a potential therapeutic alternative.

Purpose of the Study:

• To evaluate the efficacy and safety of PCI for CTO.
• To determine if PCI for CTO offers significant survival benefits compared to existing treatments.
• To identify patient subgroups who may benefit most from PCI for CTO.

Main Methods:

• Analysis of recent clinical studies, including registries and randomized trials.
• Subgroup analysis of randomized trials focusing on mortality and major adverse cardiac events.
• Assessment of myocardial ischemia and viability in patients with CTO.

Main Results:

• PCI for CTO has been demonstrated as a viable therapeutic option in recent studies.
• Significant reductions in all-cause mortality, cardiac mortality, myocardial infarction, MACE, and MACCE were not consistently demonstrated in subgroup analyses.
• PCI for CTO appears most beneficial in patients experiencing angina or having large areas of reversible myocardial ischemia.

Conclusions:

• PCI for CTO is a valid therapeutic option but requires careful patient selection.
• The decision to proceed with PCI for CTO should be individualized, considering the extent of ischemia and myocardial viability.
• Future large-scale randomized studies are needed to refine personalized approaches for PCI in CTO, balancing risks and benefits.